Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-034313
Filing Date
2009-02-23
Accepted
2009-02-20 18:38:35
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 997510
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 11848
3 CEO CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) dex311.htm EX-31.1 5855
4 CFO CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) dex312.htm EX-31.2 5864
5 CEO CERTIFICATION PURSUANT TO RULE 13A-14(B)/15D-14(B) dex321.htm EX-32.1 2414
6 CFO CERTIFICATION PURSUANT TO RULE 13A-14(B)/15D-14(B) dex322.htm EX-32.2 2451
7 GRAPHIC g22780tx28.jpg GRAPHIC 61594
  Complete submission text file 0001193125-09-034313.txt   1112448
Mailing Address 15295 ALTON PARKWAY IRVINE CA 92618
Business Address 15295 ALTON PARKWAY IRVINE CA 92618 949-788-6000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31255 | Film No.: 09626347
SIC: 2835 In Vitro & In Vivo Diagnostic Substances